🟥 Member Webinar : Hemophilia Alliance Hosts – A Clinical Overview from Novo Nordisk – A Label Update on Rebinyn, (Coagulation Factor IX (Recombinant), GlycoPEGylated: FDA Approval for a Prophylaxis Indication for Persons with Hemophilia B

All members have the option of attending our various HTC-centric events which include:

• Two in-person member meetings a year (in spring and fall)
• Regular Webinars educating our members on HTC operations & organizational management, payer relations, regulations and legal updates, and advocacy